Evidence map›Paper›PMID 42899250›Full record

ArticleCancer innovation2026

Expert Consensus on the Standardized Diagnosis, Treatment, and Management of Cancer in High-Altitude Regions of China.

Yiqun Li, Feng Li, Xiaorong Bai, Yan Li, Chengyun Bai, Qiaomei Chang, Cuiping Guo, Ji Di, Qiuxia Dong, Mengting Da and 40 more

Abstract read
In one paragraph

Article in Cancer innovation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

50 authors.

Yiqun LiNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Feng LiCancer Center, No. 941 Hospital of PLA Joint Logistics Support Force Xining Qinghai China.
Xiaorong BaiDepartment of Breast Center Gansu Cancer Hospital Lanzhou Gansu China.
Yan LiPeking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Chengyun BaiAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Qiaomei ChangAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Cuiping GuoAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Ji DiAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Qiuxia DongDepartment of Oncology Qinghai Red Cross Hospital Xining Qinghai China.
Mengting DaAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Zhongcheng LiAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Zhen LiuAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Hongxia LiangAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Yushuang LuoAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Dengfeng RenAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Pengjie YuAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Rui MaAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Miaozhou WangAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Xueshan ZhaoAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Fuxing ZhaoAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Guoshuang ShenAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Zhiping FengDepartment of Nuclear Medicine Yunnan Cancer Hospital Kunming Yunnan China.
Hao WangDepartment of Breast Surgery Sichuan Cancer Hospital Chengdu Sichuan China.
Shengtao ZhouDepartment of Oncology West China Second University Hospital, Sichuan University/West China Women's and Children's Hospital Chengdu Sichuan China.
Wenqiang WeiNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Shanshan ChenNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Lin WangNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Feng DuDepartment of Oncology Lhasa People's Hospital Lhasa Xizang Autonomous Region China.
TseyangDepartment of Oncology Lhasa People's Hospital Lhasa Xizang Autonomous Region China.
Haifeng XuDepartment of Oncology Xizang Autonomous Region People's Hospital Lhasa Xizang Autonomous Region China.
Xiaoling LingDepartment of Oncology The First Hospital of Lanzhou University Lanzhou Gansu China.
Gang XuDepartment of Oncology West China Hospital, Sichuan University Chengdu Sichuan China.
Wei GuoDepartment of Radiology Peking University Third Hospital Beijing China.
Yulan ZhaoDepartment of Oncology Xizang Autonomous Region People's Hospital Lhasa Xizang Autonomous Region China.
Die SangDepartment of Medical Oncology Sanhuan Cancer Hospital Beijing China.
Huachao FengDepartment of Medical Oncology Sanhuan Cancer Hospital Beijing China.
DeqingwangmuDepartment of Oncology Xizang Autonomous Region People's Hospital Lhasa Xizang Autonomous Region China.
GesangdejiDepartment of Oncology Xizang Autonomous Region People's Hospital Lhasa Xizang Autonomous Region China.
BasangdunzhuDepartment of Oncology Xizang Autonomous Region People's Hospital Lhasa Xizang Autonomous Region China.
BianbazhaxiDepartment of Oncology Xizang Autonomous Region People's Hospital Lhasa Xizang Autonomous Region China.
Yixin GuoAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Xinlong TaoAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.
Guohui BaiDepartment of Oncology Xizang Autonomous Region People's Hospital Lhasa Xizang Autonomous Region China.
Wanpeng YangDepartment of Oncology Xizang Autonomous Region People's Hospital Lhasa Xizang Autonomous Region China.
Hanhuan LuoDepartment of Oncology Xizang Autonomous Region People's Hospital Lhasa Xizang Autonomous Region China.
Yanming LeiDepartment of Oncology Xizang Autonomous Region People's Hospital Lhasa Xizang Autonomous Region China.
CidanwangjiuDepartment of Oncology Xizang Autonomous Region People's Hospital Lhasa Xizang Autonomous Region China.
Fei MaNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Dong WuPeking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Jiuda ZhaoAffiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Qinghai University Xining Qinghai China.ORCID https://orcid.org/0000-0002-1266-8943

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer has become one of the major diseases threatening the health of the Chinese population. The incidence of cancer in high-altitude regions of China is equally concerning. However, due to the unique geographical environment, population, and economic factors in high-altitude regions, there is an urgent need for a consensus on cancer prevention and management tailored to real-world clinical practice. To promote and standardize the diagnosis and treatment of cancer in high-altitude regions, under the leadership of the Breast Cancer Expert Committee of the National Cancer Quality Control Center and the Cancer Prevention and Treatment Committee of the Healthy China Research Center, experts in the field of high-altitude medicine were convened to jointly formulate the "Expert Consensus on the Standardized Diagnosis, Treatment, and Management of Cancer in High-Altitude Regions of China." This consensus serves as a reference for clinicians in high-altitude regions.

Indexed as

consensusdiagnosishigh‐altitude regionsmalignant tumorprevention and controltreatment

Identifiers

PMID42899250
PMCPMC13679837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.